We updated the design of this site on September 25th. Learn more.

Stratus Versus Cirrus OCT in AMD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified December 2007 by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery.
Recruitment status was: Recruiting

Sponsor:

ClinicalTrials.gov Identifier:

NCT00568191

First Posted: December 5, 2007

Last Update Posted: December 5, 2007

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by:

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Purpose

The Cirrus OCT provides due to the spectral domain technology a 2-fold resolution than Stratus OCT generated in a comparable amount of time. Due to this higher resolution the retinal surface and the retinal pigment epithelium can be identified more clearly, a significantly reduced number of algorithm failures is expected

Condition
Age-Related Macular Degeneration Choroidal Neovascularization


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Reliability of Threshold Algorithm in Age-Related Macular Degeneration: Stratus Versus Cirrus OCT

Resource links provided by NLM:

Genetics Home Reference related topics: age-related macular degeneration

MedlinePlus related topics: Macular Degeneration

Genetic and Rare Diseases Information Center resources: Uveal Diseases

U.S. FDA Resources

Further study details as provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:

Primary Outcome Measures:

Number of algorithm failures assessed by Stratus OCT versus Cirrus OCT in the horizontal central line [ Time Frame: only 1 examination ]

Secondary Outcome Measures:

Number of algorrithm failures in Stratus versus Cirrus OCT assessed in the whole scan [ Time Frame: 1 examination ]


Estimated Enrollment:	100
Study Start Date:	October 2007
Estimated Study Completion Date:	December 2007

Groups/Cohorts
1 retinal thickness program Stratus OCT software 4.0
2 retinal cube 200x200 program of Cirrus OCT

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	55 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients aged > 55 years of either sex presenting with age-related macular degeneration

Criteria

Inclusion Criteria:

Age>55 years
Age-related macular degeneration

Exclusion Criteria:

Not consented patients

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00568191

Contacts


Contact: Ilse Krebs, MD	+43171165 ext 94607	Ilse.Krebs@wienkav.at

Locations


Austria
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery	Recruiting
Vienna, Austria, A1030
Contact: Ilse Krebs, MD +43171165 ext 4607 Ilse.Krebs@wienkav.at
Principal Investigator: Ilse Krebs, MD

Sponsors and Collaborators

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Investigators


Principal Investigator:	Ilse Krebs	Ludwig Boltzmann Institute of Retinology and Biomicroscopic Lasersurgery

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Krebs I, Falkner-Radler C, Hagen S, Haas P, Brannath W, Lie S, Ansari-Shahrezaei S, Binder S. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci. 2009 Mar;50(3):995-1000. doi: 10.1167/iovs.08-2617. Epub 2008 Nov 21.


Responsible Party:	Prof Susanne Binder, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
ClinicalTrials.gov Identifier:	NCT00568191 History of Changes
Other Study ID Numbers:	EK 06-007-VK1
First Submitted:	December 4, 2007
First Posted:	December 5, 2007
Last Update Posted:	December 5, 2007
Last Verified:	December 2007

Keywords provided by The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery:


Age-related macular degeneration choroidal neovascularization Stratus OCT Cirrus OCT

Additional relevant MeSH terms:


Macular Degeneration Neovascularization, Pathologic Choroidal Neovascularization Retinal Degeneration Retinal Diseases	Eye Diseases Metaplasia Pathologic Processes Choroid Diseases Uveal Diseases

To Top